EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Improved exposure of curcumin-loaded nanocapsules: drug quantification in LPS-induced Drosophila melanogaster and pharmacokinetics in Wistar rats

Ana Pozzato Funghetto-Ribeiro, Camila de Oliveira Pacheco, Flávia Elizabete Guerra Teixeira, Joane Ferreira, Eliana Fernandes, Gustavo Guerra, Francine Johansson Azeredo, Sandra Elisa Haas

Frontiers in Pharmacology · 01.12.2025 · 16

DOI: 10.3389/fphar.2025.1688992 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Frontiers in Pharmacology, online erschienen am 01.12.2025. Verfasst von Ana Pozzato Funghetto-Ribeiro und 7 weiteren Autor:innen. Beteiligte Einrichtung: Graduate Program in Biochemistry, Federal University of Pampa (Unipampa), Uruguaiana, Rio Grande do Sul, Brazil. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 56 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Coordenação de Aperfeiçoamento de Pessoal de Nível Superior, Conselho Nacional de Desenvolvimento Científico e Tecnológico.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Curcumin (CUR) has broad pharmacological potential; however, its clinical efficacy is hindered by low aqueous solubility, extensive presystemic metabolism, and poor oral bioavailability. Nanoencapsulation strategies have been proposed to overcome these limitations.

Methods

We evaluated the exposure of poly(ε-caprolactone) nanocapsules coated with polysorbate 80 containing CUR (NC-CUR) using a validated bioanalytical approach capable of quantifying CUR in whole-body homogenates of Drosophila melanogaster and in rat plasma. Healthy and LPS-challenged flies were chronically treated with CUR or NC-CUR (37 or 110 ng/mL) for 10 days through dietary exposure. Male Wistar rats received a single intravenous (2 mg/kg) or oral (6 mg/kg) dose of CUR or NC-CUR to characterize systemic pharmacokinetics.

Results

In vitro release followed a biexponential profile, with NC-CUR showing significantly prolonged release compared to free CUR (t 1/2β = 25.79 ± 0.87 h vs. 3.15 ± 1.37 h; p < 0.0001). A validated HPLC-PDA method (LLOQ = 3 ng/mL; R 2 ≥ 0.997) enabled CUR quantification in whole flies and rat plasma. Chronic dietary exposure resulted in markedly higher CUR concentrations in flies treated with NC-CUR than free CUR (up to ∼200 vs. 75 ng/mL; p < 0.001), including under LPS-induced inflammatory conditions. In rats, NC-CUR increased systemic exposure following both intravenous (AUC 0-∞ : 1337.8 ± 385.2 vs. 100.4 ± 24.4 h⋅ng/mL; 13.3-fold, p < 0.0001) and oral administration (82.23 ± 31.68 vs. 25.55 ± 7.17 h⋅ng/mL; 3.2-fold, p < 0.01), reduced clearance (0.57 ± 0.18 vs. 7.71 ± 1.81 L/h; p < 0.0001), and accelerated absorption after oral dosing (T max : 0.58 ± 0.12 vs. 1.31 ± 0.28 h; p < 0.05).

Discussion

Nanoencapsulation significantly enhanced CUR exposure in both invertebrate and mammalian systems. This cross-species analytical strategy supports D. melanogaster as a complementary quantitative platform for early pharmacokinetic screening and reinforces NC-CUR as a promising formulation for future translational development in inflammatory conditions.

Schlagwörter

Stichwörter der Autor:innen

NAMsbioavailabilitydrug deliverypharmacokineticspolymeric nanocapsules

Autor:innen und Institutionen

  • Graduate Program in Biochemistry, Federal University of Pampa (Unipampa), Uruguaiana, Rio Grande do Sul, Brazil.
  • Pharmacology and Pharmacometric Laboratory, LABFAR, Federal University of Pampa (Unipampa), Uruguaiana, Rio Grande do Sul, Brazil.
  • Graduate Program in Pharmaceutical Sciences, Federal University of Santa Maria (UFSM), Santa Maria, Rio Grande do Sul, Brazil.
  • Laboratory of Pharmacological and Toxicological Evaluations Applied to Bioactive Molecules, LaftamBio Pampa, Federal University of Pampa (Unipampa), Itaqui, Rio Grande do Sul, Brazil.
  • Center for Pharmacometrics and Systems Pharmacology, CPSP, University of Florida, Orlando, FL, United States.

Förderung

  • Coordenação de Aperfeiçoamento de Pessoal de Nível Superior
  • Conselho Nacional de Desenvolvimento Científico e Tecnológico

Zitieren

APA

Funghetto-Ribeiro, A. P., Pacheco, C. O., Teixeira, F. E. G., Ferreira, J., Fernandes, E., Guerra, G., Johansson Azeredo, F., & Haas, S. E. (2025). Improved exposure of curcumin-loaded nanocapsules: drug quantification in LPS-induced Drosophila melanogaster and pharmacokinetics in Wistar rats. Frontiers in Pharmacology, 16. https://doi.org/10.3389/fphar.2025.1688992

Vancouver

Funghetto-Ribeiro AP, Pacheco CO, Teixeira FEG, Ferreira J, Fernandes E, Guerra G, et al. Improved exposure of curcumin-loaded nanocapsules: drug quantification in LPS-induced Drosophila melanogaster and pharmacokinetics in Wistar rats. Frontiers in Pharmacology. 2025;16. doi:10.3389/fphar.2025.1688992

BibTeX
@article{FunghettoRibeiro2025,
  author = {Funghetto-Ribeiro, Ana Pozzato and Pacheco, Camila de Oliveira and Teixeira, Flávia Elizabete Guerra and Ferreira, Joane and Fernandes, Eliana and Guerra, Gustavo and Johansson Azeredo, Francine and Haas, Sandra Elisa},
  title = {Improved exposure of curcumin-loaded nanocapsules: drug quantification in LPS-induced Drosophila melanogaster and pharmacokinetics in Wistar rats},
  journal = {Frontiers in Pharmacology},
  year = {2025},
  volume = {16},
  doi = {10.3389/fphar.2025.1688992}
}
Kostenlos starten →